Projects per year
Personal profile
Education
- 2009 Ph.D., Graduate Institute of Clinical Medicine, Taipei Medical University
- 1985-1992 M.D., School of Medicine, National Taiwan University
Experience
- 2025.01- Superintendent,Taipei Cancer Center, Taipei Medical University
- 2023.04-2025.07 Vice Superintendent, Taipei Medical University Hospital
- 2017.08- Professor, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2015.08- Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2015.08- Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2014.08- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2014.02- Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical university
- 2021.08-2023.08 Chairman, Department of Quality Management, Taipei Medical University Hospital
- 2019.01-2023.04 Vice Superintendent, Taipei Medical University Hospital
- 2020.11-2021.07 Director, Department of Nuclear Medicine, Taipei Medical University Hospital
- 2016.06-2017.07 Deputy Director, School of Medicine, College of Medicine, Taipei Medical University
- 2015 Vice Chairman, Department of Surgery, Taipei Medical University Hospital
- 2015.08-2016.07 Chairman, Department of Quality Management, Taipei Medical University Hospital
- 2012.08-2015.07 Associate Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2009.08-2012.07 Assistant Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2008 Chief, Division of General Surgery, Taipei Medical University Hospital
- 2006 Attending Doctor, General Surgery, Taipei Medical University Hospital
- 2006.02-2009.07 Instructor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2005.12-2006.05 Director, Division of Rectal Surgery, Min-Sheng Hospital
- 2004.07-2005.11 Director, Division of General Surgery, En Chu Kong Hospital
- 2003.07-2004.06 Director, Division of Rectal Surgery, En Chu Kong Hospital
- 1997.07-2006.06 Attending Physician, Department of Surgery, En Chu Kong Hospital
- 1992.07-1997.06 Resident Physician, Department of Surgery, National Taiwan University Hospital
Awards
- 2015 Faculty Award of Taipei Medical University
- 2015 Distinguished Teaching Award of College of Medicine, Taipei Medical University
- 2013 Best Advisor Award of College of Medicine, Taipei Medical University
- 2011 The excellent thesis of the year 2010 by international college of surgeons
Research Interests
- Cancer molecular biology
- Signal transduction
- ER stress and metastasis
- Colorectal Surgery
Related Link
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 4 Quality Education -
SDG 5 Gender Equality
Fingerprint
Dive into the research topics where Po-Li Wei is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 18 Finished
-
Investigating the Role of Slc35d1 in Colorectal Cancer Progression and Chemoresistance
Wei, P.-L. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Investigating the Role of Slc35d1 in Colorectal Cancer Progression and Chemoresistance
Wei, P.-L. (PI)
8/1/23 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Investigate the Regulatory Mechanism and Therapeutic Roles of Msn in Colorectal Cancer (Continuation Project)
Wei, P.-L. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Investigate the Regulatory Mechanism and Therapeutic Roles of Msn in Colorectal Cancer
Wei, P.-L. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
探討PCTK1激?蛋白在大腸直腸癌發展的角色及其調控機制(延續計畫)(3/3)
Wei, P.-L. (PI)
8/1/20 → 7/1/21
Project: A - Government Institution › b - National Science and Technology Council
-
ALDH2 regulates oxaliplatin sensitivity via PDE4B in p53-mutant colorectal cancer
Wei, P. L., Huang, C. Y., Lee, C. C., Batzorig, U., Tsai, K. Y. & Chang, Y. J., 2026, In: International Journal of Medical Sciences. 23, 9, p. 2835-2846 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Integrating quality, risk, and environmental impact in sustainable operating rooms: A perioperative perspective from Taiwan
Chiu, H. Y., Liao, H. W. & Wei, P. L., 2026, In: Journal of the Formosan Medical Association.Research output: Contribution to journal › Short survey › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Surgeon educators are infrastructure: Governing surgical training at scale
Chiu, H. Y., Chen, C. Y. & Wei, P. L., 2026, In: American Journal of Surgery. 258, 116988.Research output: Contribution to journal › Editorial › peer-review
1 Link opens in a new tab Citation (Scopus) -
Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial
Chia, J. W. K., Segelov, E., Deng, Y., Ho, G. F., Wang, W., Han, S., Sharma, A., Ding, K., Chen, G., Jeffery, M. G., Tham, C. K., Ahn, J. B., Nott, L., Zielinski, R., Chao, T.-Y., van Hagen, T., Wei, P.-L., Day, F., Mehta, S. & Yau, T. & 10 others, , Mar 2025, In: The Lancet Gastroenterology and Hepatology. 10, 3, p. 198-209 12 p.Research output: Contribution to journal › Article › peer-review
30 Link opens in a new tab Citations (Scopus) -
Correction to: Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling (Biomedicines, (2022), 10, 2, (377), 10.3390/biomedicines10020377)
Leung, W. H., Shih, J. W., Chen, J. S., Mokgautsi, N., Wei, P. L. & Huang, Y. J., Mar 2025, In: Biomedicines. 13, 3, 547.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Link opens in a new tab Citation (Scopus)
Datasets
-
Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial
Yeh, Y.-S. (Contributor), Tsai, H.-L. (Contributor), Huang, C.-W. (Creator), Wei, P.-L. (Contributor), Sung, Y.-C. (Contributor), Tang, H.-C. (Contributor) & Wang, J.-Y. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3751544.v1, https://doi.org/10.6084%2Fm9.figshare.c.3751544.v1
Dataset
-
Additional file 1 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
Cheng, Y.-W. (Creator), Cheng, C.-C. (Creator), HuangFu, W.-C. (Creator), Pan, S.-L. (Creator), Sung, T.-Y. (Creator), Chang, F.-L. (Creator), Huang, H.-L. (Contributor), Huang, C.-C. (Contributor), Wei, P.-L. (Contributor) & Lee, Y.-C. (Contributor), Figshare, 2021
DOI: 10.6084/m9.figshare.14228278.v1, https://doi.org/10.6084%2Fm9.figshare.14228278.v1
Dataset
-
Additional file 2: Figure S1. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huynh, T.-T. (Contributor), Tzeng, Y.-M. (Contributor), Yen, Y. (Creator), Yang, C.-K. (Contributor), Wu, A. T. (Creator), Meng, T.-C. (Contributor), Whang-Peng, J. (Creator), Wei, P.-L. (Contributor), Hsiao, M. (Creator) & Huang, Y.-J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3704533_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3704533_d1.v1
Dataset
-
Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huang, Y.-J. (Contributor), Yang, C.-K. (Contributor), Wei, P.-L. (Contributor), Huynh, T.-T. (Contributor), Whang-Peng, J. (Creator), Meng, T.-C. (Contributor), Hsiao, M. (Creator), Tzeng, Y.-M. (Contributor), Wu, A. T. (Creator) & Yen, Y. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3704533.v1, https://doi.org/10.6084%2Fm9.figshare.c.3704533.v1
Dataset
-
Additional file 1: of Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial
Tsai, H.-L. (Contributor), Sung, Y.-C. (Contributor), Tang, H.-C. (Contributor), Yeh, Y.-S. (Contributor), Wei, P.-L. (Contributor), Wang, J.-Y. (Contributor) & Huang, C.-W. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3751544_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3751544_d1.v1
Dataset